Ryotaro Nakamura
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
3
NIH RePORTER
Trial papers in chronic myeloid leukemia
0
PubMed author-name match
Trials
Studies that name Ryotaro Nakamura as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:17 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07664670 · The High Fiber Program to Increase Fiber Intake Among Patients Undergoing Allogeneic Hematopoietic Cell TransplantCity of Hope Medical Center · recruiting · Hematopoietic and Lymphatic System Neoplasm · principal investigator
- Ph1NCT07583303 · BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 MutationCity of Hope Medical Center · not yet recruiting · Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia · principal investigator
- N/ANCT07235501 · Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell TransplantationCity of Hope Medical Center · recruiting · Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm · principal investigator
- Ph1NCT07020533 · A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantCity of Hope Medical Center · recruiting · Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia · principal investigator
- Ph1NCT05757310 · A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaCity of Hope Medical Center · recruiting · Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia · principal investigator
- Ph2NCT04060277 · Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantationCity of Hope Medical Center · active not recruiting · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia · principal investigator
- Ph1NCT03922035 · CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell TransplantCity of Hope Medical Center · active not recruiting · Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- Ph1NCT03560752 · CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic TransplantCity of Hope Medical Center · active not recruiting · Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission · principal investigator
- Ph2NCT03438344 · Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantCity of Hope Medical Center · withdrawn · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission · principal investigator
- Ph2NCT02506933 · Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell TransplantCity of Hope Medical Center · active not recruiting · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission · principal investigator
- Ph2NCT02396134 · Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantCity of Hope Medical Center · completed · Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission · principal investigator
- Ph1NCT01588015 · Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCity of Hope Medical Center · completed · Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission · principal investigator
- N/ANCT01199562 · Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantCity of Hope Medical Center · active not recruiting · Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia · principal investigator
- Ph1NCT00720135 · Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaCity of Hope Medical Center · completed · Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue · principal investigator
- Ph2NCT00589563 · Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerCity of Hope Medical Center · completed · Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- BMT CTN Core - City of Hope National Medical CenterUG1HL069278 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2017 to 2026 · $264,000 awarded in 2026Same name and institution; not confirmed by an ID
- CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHLR01CA296280 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2025 to 2026 · $738,698 awarded in 2026Same name and institution; not confirmed by an ID
- Blood and Marrow Transplant Clinical Research NetworkU10HL069278 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2012 to 2016 · $173,880 awarded in 2016Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2012 to 2026
- Role of autoreactivity in pathogenesis of chronic graft versus host diseaseR01HL170099 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Robert Jenq · fiscal years 2024 to 2026Named on NCT07235501
- Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccineR01CA077544 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Don J Diamond · fiscal years 2013 to 2017Named on NCT02506933
- CMVPepVax to Protect HCT Recipients from Cytomegalovirus InfectionR01CA181045 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Don J Diamond · fiscal years 2014 to 2018Named on NCT02396134
- GMP ManufacturingP50CA107399 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LARRY W KWAK · fiscal years 2012 to 2022Named on NCT00720135
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.